Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vladimir Murugin"'
Autor:
Mikhail Melnikov, Svetlana Sharanova, Anastasiya Sviridova, Vladimir Rogovskii, Nina Murugina, Anna Nikolaeva, Yulia Dagil, Vladimir Murugin, Tatiana Ospelnikova, Alexey Boyko, Mikhail Pashenkov
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240305 (2020)
Glatiramer acetate (GA) is approved for the treatment of multiple sclerosis (MS). However, the mechanism of action of GA in MS is still unclear. In particular, it is not known whether GA can modulate the pro-inflammatory Th17-type immune response in
Externí odkaz:
https://doaj.org/article/faa5b240c1da436eb10222a7f1b195a2
Autor:
V. M. Ukrainskaya, Denis Y. Logunov, Alexandra V. Maleeva, O. Ivanova, Inna V. Dolzhikova, Grigory A. Efimov, Iuliia O. Peshkova, Leila Ovchinnikova, Elizaveta Romanova, Savely A. Sheetikov, Alexandra Gracheva, Ksenia V. Zornikova, Alexander Mitin, Ioanna N. Filimonova, Anna Tvorogova, Alexey A. Komissarov, Nelli B. Naigovzina, Anna Navoikova, Mikhail Pashenkov, Yakov A. Lomakin, Liudmila Shevkova, Aleksander Deryabin, Anna Panova, D. Vorobyeva, E. Maryukhnich, N. Pinegina, Yury P. Rubtsov, Denis Lagutkin, Musa Khaitov, Viktoria Komogorova, Yana Serdyuk, Oksana Musatova, Walaa Asaad, Irina Vasilyeva, Anastasia Samoilova, Vladimir Murugin, Afraa Mohammad, Pavel Volchkov, Anatoliy Vinokurov, Daria Potashnikova, Natalia Kompantseva, Ivan Molodtsov, Anastasia Kizilova, Evgenii Kegeles, Nawar Sakr, Anna Trufanova, Alexander Shpektor, Elena Vasilieva, Aleena Saidova, Olga Mityaeva, Nina Murugina, Naina T. Shakirova, Nina Sharova, Anastasia Komova, Ilya Kofiadi, Anastasia Shemetova, Anna Budikhina, Margarita Nikonova, Alsalloum Almaqdad
Background Coronavirus disease COVID-19 has spread worldwide extremely rapidly. Although many individuals have been infected and have cleared the virus, developing virus-specific antibodies and effector/memory T cells, an important question still to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ad609d16d6841d8058374892924746a
https://doi.org/10.1101/2021.08.19.21262278
https://doi.org/10.1101/2021.08.19.21262278
Autor:
Mikhail, Melnikov, Anastasiya, Sviridova, Vladimir, Rogovskii, Vladimir, Kudrin, Vladimir, Murugin, Alexey, Boyko, Mikhail, Pashenkov
Publikováno v:
Current neuropharmacology. 20(8)
Dopamine is one of the main mediators capable regulate the neuroimmune interaction and is involved in multiple sclerosis (MS) pathogenesis.The aim of this study was to clarify the role of dopamine and its receptors in modulation of Th17-cells in MS.3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1c4427b6e94343921b69eace0c321c9
https://pubmed.ncbi.nlm.nih.gov/34429055
https://pubmed.ncbi.nlm.nih.gov/34429055
Publikováno v:
Journal of Neuroimmunology. 292:97-101
Neuromediators may modulate neuroinflammation, particularly in multiple sclerosis (MS). We investigated the effects of dopamine (DA) on the pro-inflammatory Th17-branch of immunity in 43 patients with relapsing-remitting MS and 20 healthy subjects. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e79de1903166b799eb5978ba09bddf8
https://doi.org/10.1016/j.jneuroim.2016.01.020
https://doi.org/10.1016/j.jneuroim.2016.01.020